Tagged oncology
Press Release
University of Illinois Urbana-Champaign and Mayo Clinic Researchers Develop New Technique to Study 'Microcancers' and Screen Cancer-Fighting Drugs
Three-dimensional microscale hanging drop arrays are useful in drug discovery, regenerative medicine, stem cell research, and biotechnology. Read More
Press Release
Almac Discovery to Present Updates on Key Oncology Programmes at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
Presentations highlight significant new data for key oncology drug development programmes - USP7 small molecule inhibitors and ROR1 Protein: Drug Conjugates Read More
Press Release
Syndivia In-Licenses DARx Technology for 1-to-1 Linkage of Antibodies and Payloads for Preparation of New Classes of Biologics
Syndivia receives the exclusive license from SATT Conectus to DARx technology, which allows them to generate monodisperse 1-to-1 conjugates starting from off the shelf protein substrates (e.g., therapeutic antibodies). Antibody-drug and antibody-oligonucleotide conjugates with a degree of conjugation of 1 (DAR1), obtained using DARx, were demonstrated to have improved therapeutic indexes due to improved PK/PD parameters. Read More
Press Release
Syndivia In-Licenses Novel Antibody Against Tumor-Specific Form of CD146 From SATT Sud-Est
Syndivia receives the exclusive sublicense specifically for immunoconjugates of the monoclonal antibody against the tumor-specific form of CD146 (CD146-ts mAb), which represents a first-in-class opportunity for the treatment of a number of solid cancers, including melanoma and pancreatic cancer. Read More
Press Release
